Submissions by Replace this line with your name replace.with.your@email.id GitHub:@obonac

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task added at URL https://github.com/udhc-journals/udhc-journals.github.io/issues/19

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

The dataset has been updated vide commit id 4f51e77611a8c1944c763c318fb98bd00f9be513

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id dcbf124a320687aee355e6be00dd8b9ccee18495

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/20

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 81165482dbe3b96c0da5efb3b3b3313543f568e3

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id cce70f617cec992b4149a062c2e0def3ef524869

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/22

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 81165482dbe3b96c0da5efb3b3b3313543f568e3

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id cce70f617cec992b4149a062c2e0def3ef524869

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/25

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 81165482dbe3b96c0da5efb3b3b3313543f568e3

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id cce70f617cec992b4149a062c2e0def3ef524869

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/28

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 81165482dbe3b96c0da5efb3b3b3313543f568e3

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id cce70f617cec992b4149a062c2e0def3ef524869

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/30

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 81165482dbe3b96c0da5efb3b3b3313543f568e3

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id cce70f617cec992b4149a062c2e0def3ef524869

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/33

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 59f9b380fb6b6f2e1ec4cb1016ae21fcc44984cc

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id 6491292600373aae9fadd554085d8757d1718c43

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/34

[obonac]

Escrowal links generated at 1667716708 Link to escrow PR "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11", Link to escrow Issue (workflow task) "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/issues/34", Link to escrow Auth "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth", Link to escrow uploaded data "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth",

[obonac]

Escrowal links generated at 1667716708 Link to escrow PR "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11", Link to escrow Issue (workflow task) "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/issues/34", Link to escrow Auth "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth", Link to escrow uploaded data "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth", The above links were generated for escrowal

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 9da36285fbc8671168fbad629f49c8ea4049c853

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id e340eb1395974c3ef15ea1bd9c104915a55643db

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/35

[obonac]

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 28 Oct 2022 19:04:57 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-exclusively-reports-twitter-struggles-to-keep-its-most-active-users-engaged-ahead-of-musk-deal/ Wed, 26 Oct 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296397 Reuters exclusively reported the deterioration of Twitter’s service, days ahead of Elon Musk’s $44 billion deal to buy the social media platform. […]

The post Reuters exclusively reports Twitter struggles to keep its most active users engaged ahead of Musk deal appeared first on Reuters News Agency.

]]>

Reuters exclusively reported the deterioration of Twitter’s service, days ahead of Elon Musk’s $44 billion deal to buy the social media platform. Based on internal documents, reviewed by Reuters, the report examined how Twitter has struggled to keep its most active users — and biggest driver of revenue —engaged. These users, who account for the vast majority of tweets on the service, are also increasingly less interested in news and entertainment and have shifted their attention to pornography and crypto. The findings underscore the myriad of challenges Musk will face to restructure the company.

The post Reuters exclusively reports Twitter struggles to keep its most active users engaged ahead of Musk deal appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-alleges-seagate-broke-export-rules-to-sell-huawei-hard-drives/ Wed, 26 Oct 2022 17:39:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296289 Reuters exclusively revealed Seagate Technology Holdings said in a filing that the U.S. government has warned the company that it […]

The post Reuters reveals U.S. alleges Seagate broke export rules to sell Huawei hard drives appeared first on Reuters News Agency.

]]> Reuters exclusively revealed Seagate Technology Holdings said in a filing that the U.S. government has warned the company that it may have violated export control laws by providing hard disk drives to a customer that a source familiar with the situation identified as Huawei Technologies. Huawei is on the U.S. Commerce Department’s entity list and banned from receiving U.S. exports and certain foreign-made items without government approval.

The post Reuters reveals U.S. alleges Seagate broke export rules to sell Huawei hard drives appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-microsoft-powers-up-search-for-chinese-gaming-hits-in-race-against-sony/ Tue, 25 Oct 2022 17:51:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296337 Reuters was first to report Microsoft Corp is stocking up on Chinese video game content to emulate Sony Group Corp’s […]

The post Reuters reveals Microsoft powers up search for Chinese gaming hits in race against Sony appeared first on Reuters News Agency.

]]>

Reuters was first to report Microsoft Corp is stocking up on Chinese video game content to emulate Sony Group Corp’s success with “Genshin Impact”, solidifying China’s transition from a land only of players to a hub of blockbuster developers.

The post Reuters reveals Microsoft powers up search for Chinese gaming hits in race against Sony appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-exclusively-reveals-sap-delays-russia-exit-as-deal-talks-fail-workers-at-risk/ Mon, 24 Oct 2022 19:01:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296409 Reuters exclusively reported German software group SAP will delay its exit from Russia months after it declared the company would […]

The post Reuters exclusively reveals SAP delays Russia exit as deal talks fail, workers at risk appeared first on Reuters News Agency.

]]> Reuters exclusively reported German software group SAP will delay its exit from Russia months after it declared the company would do so. The Reuters report examined the intricacies global companies like SAP faced trying to extricate from the controversial market. These problems include grappling with existing contractual obligations and facing pressure from the government over speedy exits. Moments before Reuters revealed the news, SAP confirmed the report, which helped wipe out $2.5 billion from its market cap before leveling off by the end of the trading day. Read on Eikon.

The post Reuters exclusively reveals SAP delays Russia exit as deal talks fail, workers at risk appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-korean-auto-giant-hyundai-investigating-child-labor-in-its-u-s-supply-chain/ Fri, 21 Oct 2022 17:50:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296325 Reuters exclusively revealed that Hyundai Motor Co, Korea’s top automaker, is investigating child labor violations in its U.S. supply chain […]

The post Reuters reveals Korean auto giant Hyundai investigating child labor in its U.S. supply chain appeared first on Reuters News Agency.

]]> Reuters exclusively revealed that Hyundai Motor Co, Korea’s top automaker, is investigating child labor violations in its U.S. supply chain and plans to sever ties with Hyundai suppliers in Alabama found to have relied on underage workers. A Reuters investigative report in July documented children, including a 12-year-old, working at a Hyundai-controlled metal stamping plant in rural Alabama. 

The post Reuters reveals Korean auto giant Hyundai investigating child labor in its U.S. supply chain appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-germanys-speira-set-to-win-eu-nod-for-rab-deal-with-asset-sale-offer/ Tue, 18 Oct 2022 18:40:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296185 Reuters was first to report private equity firm KPS Capital Partners’ German aluminium smelter Speira is set to gain European […]

The post Reuters reveals Germany’s Speira set to win EU nod for RAB deal with asset sale offer appeared first on Reuters News Agency.

]]> Reuters was first to report private equity firm KPS Capital Partners’ German aluminium smelter Speira is set to gain European Union (EU) antitrust approval for its plan to buy aluminium recycler Real Alloy Europe with its offer to sell two plants to address EU concerns.

The post Reuters reveals Germany’s Speira set to win EU nod for RAB deal with asset sale offer appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-toshibas-preferred-bidder-offers-price-short-of-key-6000-yen-a-share/ Mon, 17 Oct 2022 17:33:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296113 Reuters was first to report the preferred bidder to buy out Toshiba Corp has offered to pay less than the […]

The post Reuters reveals Toshiba’s preferred bidder offers price short of key 6,000 yen a share appeared first on Reuters News Agency.

]]>

Reuters was first to report the preferred bidder to buy out Toshiba Corp has offered to pay less than the widely regarded threshold of 6,000 yen a share, indicating the premium for the Japanese conglomerate may not be as rich as investors had hoped.

The post Reuters reveals Toshiba’s preferred bidder offers price short of key 6,000 yen a share appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-judge-approves-sales-process-for-shares-in-citgo-petroleums-parent-company/ Tue, 11 Oct 2022 19:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296233 Reuters was first to report that a U.S. judge approved an auction process that could lead to the breakup of […]

The post Reuters reveals U.S. judge approves sales process for shares in Citgo Petroleum’s parent company appeared first on Reuters News Agency.

]]> Reuters was first to report that a U.S. judge approved an auction process that could lead to the breakup of Venezuela owned Citgo Petroleum, the seventh-largest  U.S. oil refiner. Two years after first authorizing a sale of shares in Citgo’s parent company, PDVSA, the judge set bidding procedures and a calendar that could see a high bid accept within nine months to satisfy a $970 million judgment won by a Canadian miner over the expropriation of its assets in Venezuela. Reuters also revealed four other companies with $4.3 billion in combined claims against Venezuela — ConocoPhillips, Koch-related mineral and nitrogen companies, Gold Reserve Inc. and U.S. holders of defaulted Venezuelan bonds —  were seeking to have their own judgments registered with the same court. 

The post Reuters reveals U.S. judge approves sales process for shares in Citgo Petroleum’s parent company appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-assa-abloy-considers-selling-yale-and-emtek-brands-to-win-u-s-approval-for-spectrum-deal/ Fri, 07 Oct 2022 13:13:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295917 Reuters was first to report that Assa Abloy, the world’s leading lockmaker, is considering options including selling its Yale and […]

The post Reuters reveals Assa Abloy considers selling Yale and Emtek brands to win U.S. approval for Spectrum deal appeared first on Reuters News Agency.

]]> Reuters was first to report that Assa Abloy, the world’s leading lockmaker, is considering options including selling its Yale and Emtek locks brands as it seeks to overturn U.S. antitrust opposition to its planned purchase of Spectrum’s Hardware and Home Improvement. The news comes just weeks after the U.S. Department of Justice sued to block the company’s proposed $4.3 billion deal to buy a unit of Spectrum Brands Holdings that makes security, plumbing and builders’ hardware products.

The post Reuters reveals Assa Abloy considers selling Yale and Emtek brands to win U.S. approval for Spectrum deal appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-general-electric-lays-off-workers-at-onshore-wind-unit-as-part-of-turnaround-strategy/ Thu, 06 Oct 2022 20:59:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295880 Reuters was first to report General Electric (GE) is laying off workers at its onshore wind unit as part of a plan […]

The post Reuters reveals General Electric lays off workers at onshore wind unit as part of turnaround strategy appeared first on Reuters News Agency.

]]> Reuters was first to report General Electric (GE) is laying off workers at its onshore wind unit as part of a plan to restructure and resize the business. The cuts are expected to affect 20% of the onshore wind unit’s workforce in the United States, equating to hundreds of workers. The company also notified employees in Latin America, the Middle East and Africa about the cuts. The news revealed problems with what is widely thought to be a fast-growing clean energy economy. GE and competitors have grappled with rising costs and supply chain delays, despite the energy transition. 

The post Reuters reveals General Electric lays off workers at onshore wind unit as part of turnaround strategy appeared first on Reuters News Agency.

]]>

[obonac]

Title: Paste the submission title here Abstract: Paste your abstract here

---

Upload details

I assert that dataset has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The dataset has been updated vide commit id 9da36285fbc8671168fbad629f49c8ea4049c853

---

Authorization details

I assert that data access authorization has been uploaded with following fingerprint dummy_data : 3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df

  dummy_auth : 46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a

The authorization has been updated vide commit id e340eb1395974c3ef15ea1bd9c104915a55643db

---

I further assert that I am solely responsible for the uploaded dataset being compliant with the terms of the authorization, and thereof indemnify AyeAI Consulting its agents, employees and partners against any direct or indirect losses arising out of any access, processing or sharing of this data. I understand and accept that all disputes are subject to the jurisdiction of courts in Hyderabad, Telangana, INDIA only.

Name: [Please type your full name as your signature. Name must match the name entered above] Email: [Email must be entered same as AyeAI.xyz account email] Place: [Physical location. Update before committing] Date: [Update before committing]

[obonac]

Workflow task as Issue https://github.com/udhc-journals/udhc-journals.github.io/issues/36

[obonac]

For validation and chronological verification only

Current Affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 28 Oct 2022 19:04:57 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-exclusively-reports-twitter-struggles-to-keep-its-most-active-users-engaged-ahead-of-musk-deal/ Wed, 26 Oct 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296397 Reuters exclusively reported the deterioration of Twitter’s service, days ahead of Elon Musk’s $44 billion deal to buy the social media platform. […]

The post Reuters exclusively reports Twitter struggles to keep its most active users engaged ahead of Musk deal appeared first on Reuters News Agency.

]]>

Reuters exclusively reported the deterioration of Twitter’s service, days ahead of Elon Musk’s $44 billion deal to buy the social media platform. Based on internal documents, reviewed by Reuters, the report examined how Twitter has struggled to keep its most active users — and biggest driver of revenue —engaged. These users, who account for the vast majority of tweets on the service, are also increasingly less interested in news and entertainment and have shifted their attention to pornography and crypto. The findings underscore the myriad of challenges Musk will face to restructure the company.

The post Reuters exclusively reports Twitter struggles to keep its most active users engaged ahead of Musk deal appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-alleges-seagate-broke-export-rules-to-sell-huawei-hard-drives/ Wed, 26 Oct 2022 17:39:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296289 Reuters exclusively revealed Seagate Technology Holdings said in a filing that the U.S. government has warned the company that it […]

The post Reuters reveals U.S. alleges Seagate broke export rules to sell Huawei hard drives appeared first on Reuters News Agency.

]]> Reuters exclusively revealed Seagate Technology Holdings said in a filing that the U.S. government has warned the company that it may have violated export control laws by providing hard disk drives to a customer that a source familiar with the situation identified as Huawei Technologies. Huawei is on the U.S. Commerce Department’s entity list and banned from receiving U.S. exports and certain foreign-made items without government approval.

The post Reuters reveals U.S. alleges Seagate broke export rules to sell Huawei hard drives appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-microsoft-powers-up-search-for-chinese-gaming-hits-in-race-against-sony/ Tue, 25 Oct 2022 17:51:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296337 Reuters was first to report Microsoft Corp is stocking up on Chinese video game content to emulate Sony Group Corp’s […]

The post Reuters reveals Microsoft powers up search for Chinese gaming hits in race against Sony appeared first on Reuters News Agency.

]]>

Reuters was first to report Microsoft Corp is stocking up on Chinese video game content to emulate Sony Group Corp’s success with “Genshin Impact”, solidifying China’s transition from a land only of players to a hub of blockbuster developers.

The post Reuters reveals Microsoft powers up search for Chinese gaming hits in race against Sony appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-exclusively-reveals-sap-delays-russia-exit-as-deal-talks-fail-workers-at-risk/ Mon, 24 Oct 2022 19:01:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296409 Reuters exclusively reported German software group SAP will delay its exit from Russia months after it declared the company would […]

The post Reuters exclusively reveals SAP delays Russia exit as deal talks fail, workers at risk appeared first on Reuters News Agency.

]]> Reuters exclusively reported German software group SAP will delay its exit from Russia months after it declared the company would do so. The Reuters report examined the intricacies global companies like SAP faced trying to extricate from the controversial market. These problems include grappling with existing contractual obligations and facing pressure from the government over speedy exits. Moments before Reuters revealed the news, SAP confirmed the report, which helped wipe out $2.5 billion from its market cap before leveling off by the end of the trading day. Read on Eikon.

The post Reuters exclusively reveals SAP delays Russia exit as deal talks fail, workers at risk appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-korean-auto-giant-hyundai-investigating-child-labor-in-its-u-s-supply-chain/ Fri, 21 Oct 2022 17:50:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296325 Reuters exclusively revealed that Hyundai Motor Co, Korea’s top automaker, is investigating child labor violations in its U.S. supply chain […]

The post Reuters reveals Korean auto giant Hyundai investigating child labor in its U.S. supply chain appeared first on Reuters News Agency.

]]> Reuters exclusively revealed that Hyundai Motor Co, Korea’s top automaker, is investigating child labor violations in its U.S. supply chain and plans to sever ties with Hyundai suppliers in Alabama found to have relied on underage workers. A Reuters investigative report in July documented children, including a 12-year-old, working at a Hyundai-controlled metal stamping plant in rural Alabama. 

The post Reuters reveals Korean auto giant Hyundai investigating child labor in its U.S. supply chain appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-germanys-speira-set-to-win-eu-nod-for-rab-deal-with-asset-sale-offer/ Tue, 18 Oct 2022 18:40:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296185 Reuters was first to report private equity firm KPS Capital Partners’ German aluminium smelter Speira is set to gain European […]

The post Reuters reveals Germany’s Speira set to win EU nod for RAB deal with asset sale offer appeared first on Reuters News Agency.

]]> Reuters was first to report private equity firm KPS Capital Partners’ German aluminium smelter Speira is set to gain European Union (EU) antitrust approval for its plan to buy aluminium recycler Real Alloy Europe with its offer to sell two plants to address EU concerns.

The post Reuters reveals Germany’s Speira set to win EU nod for RAB deal with asset sale offer appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-toshibas-preferred-bidder-offers-price-short-of-key-6000-yen-a-share/ Mon, 17 Oct 2022 17:33:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296113 Reuters was first to report the preferred bidder to buy out Toshiba Corp has offered to pay less than the […]

The post Reuters reveals Toshiba’s preferred bidder offers price short of key 6,000 yen a share appeared first on Reuters News Agency.

]]>

Reuters was first to report the preferred bidder to buy out Toshiba Corp has offered to pay less than the widely regarded threshold of 6,000 yen a share, indicating the premium for the Japanese conglomerate may not be as rich as investors had hoped.

The post Reuters reveals Toshiba’s preferred bidder offers price short of key 6,000 yen a share appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-judge-approves-sales-process-for-shares-in-citgo-petroleums-parent-company/ Tue, 11 Oct 2022 19:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=296233 Reuters was first to report that a U.S. judge approved an auction process that could lead to the breakup of […]

The post Reuters reveals U.S. judge approves sales process for shares in Citgo Petroleum’s parent company appeared first on Reuters News Agency.

]]> Reuters was first to report that a U.S. judge approved an auction process that could lead to the breakup of Venezuela owned Citgo Petroleum, the seventh-largest  U.S. oil refiner. Two years after first authorizing a sale of shares in Citgo’s parent company, PDVSA, the judge set bidding procedures and a calendar that could see a high bid accept within nine months to satisfy a $970 million judgment won by a Canadian miner over the expropriation of its assets in Venezuela. Reuters also revealed four other companies with $4.3 billion in combined claims against Venezuela — ConocoPhillips, Koch-related mineral and nitrogen companies, Gold Reserve Inc. and U.S. holders of defaulted Venezuelan bonds —  were seeking to have their own judgments registered with the same court. 

The post Reuters reveals U.S. judge approves sales process for shares in Citgo Petroleum’s parent company appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-assa-abloy-considers-selling-yale-and-emtek-brands-to-win-u-s-approval-for-spectrum-deal/ Fri, 07 Oct 2022 13:13:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295917 Reuters was first to report that Assa Abloy, the world’s leading lockmaker, is considering options including selling its Yale and […]

The post Reuters reveals Assa Abloy considers selling Yale and Emtek brands to win U.S. approval for Spectrum deal appeared first on Reuters News Agency.

]]> Reuters was first to report that Assa Abloy, the world’s leading lockmaker, is considering options including selling its Yale and Emtek locks brands as it seeks to overturn U.S. antitrust opposition to its planned purchase of Spectrum’s Hardware and Home Improvement. The news comes just weeks after the U.S. Department of Justice sued to block the company’s proposed $4.3 billion deal to buy a unit of Spectrum Brands Holdings that makes security, plumbing and builders’ hardware products.

The post Reuters reveals Assa Abloy considers selling Yale and Emtek brands to win U.S. approval for Spectrum deal appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-general-electric-lays-off-workers-at-onshore-wind-unit-as-part-of-turnaround-strategy/ Thu, 06 Oct 2022 20:59:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295880 Reuters was first to report General Electric (GE) is laying off workers at its onshore wind unit as part of a plan […]

The post Reuters reveals General Electric lays off workers at onshore wind unit as part of turnaround strategy appeared first on Reuters News Agency.

]]> Reuters was first to report General Electric (GE) is laying off workers at its onshore wind unit as part of a plan to restructure and resize the business. The cuts are expected to affect 20% of the onshore wind unit’s workforce in the United States, equating to hundreds of workers. The company also notified employees in Latin America, the Middle East and Africa about the cuts. The news revealed problems with what is widely thought to be a fast-growing clean energy economy. GE and competitors have grappled with rising costs and supply chain delays, despite the energy transition. 

The post Reuters reveals General Electric lays off workers at onshore wind unit as part of turnaround strategy appeared first on Reuters News Agency.

]]>

[obonac]

Escrowal links generated at 1667721769 Link to escrow PR "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11", Link to escrow Issue (workflow task) "https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/issues/36", Link to escrow Auth "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth", Link to escrow uploaded data "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data", "https://web.archive.org/save/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth", The above links were generated for escrowal

[obonac]

1667722227 https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - \n\n----------------------\nCurrent affairs\n-------------------------\n

[obonac]

1667722227 https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 3bd4c286d11aba76591c97f155e3786224d824446a94efbd5b010e06f33e8bbf - \n\n----------------------\nCurrent affairs\n-------------------------\n

[obonac]

1667722718

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 4308ad1b74c55f0df34fa8fc1cf4ea9fb7e904b43a9120b35d5021f230af56a1 - ---------------------- Current affairs -------------------------

[obonac]

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. ee46a332751348bdd77b116e64f58f6d04075754c409dea247eb0fcf70e2da91 - ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855 -

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - \n\n----------------------\nCurrent affairs\n-------------------------\n Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

----------------\nBlock chain bridge verification\n------------------\n1667723373

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. f89a7467abc2d43de8696f3a3ccc119788bc4319f27127a76a3bdcece8c43e7a - \n\n----------------------\nCurrent affairs\n-------------------------\n Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667723563

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. d114a1b2ed7caed74120897664d9f439777f634b5574533277eae601bbb64868 - For chronological validation only ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667723702

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 - For chronological validation only ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667723747

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

158a3316afeb7d9a11d6541252d092f6e06be28f4799b7d836cc593661bc4653 -

For chronological validation only

Current affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667723962

https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724066

https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724123

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d -

For chronological validation only

Current affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724263

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 8aaacdc83d5162aaa7a8eba50759dd328ae4a160e061be47fbf095675bbdea7d - For chronological validation only ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724314

https://web.archive.org/save/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724390

https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/pull/11

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - https://web.archive.org/web//https://github.com/udhc-journals/udhc-journals.github.io/issues/36

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - https://web.archive.org/web//https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Redirecting...

You should be redirected automatically to target URL: /. If not click the link. 5ce75ed436e5788f3494cf86a59fb7440fb06bee8069df53a8a920c925a5045c - For chronological validation only ---------------------- Current affairs ------------------------- Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667724697

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

00d0c6fa9c06e923df301546eea69d92291f771bffe1eb41271b235b07608df2 -

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/issues/36

56944f278a573144994d0c9e2d586f725938cc1ece766cca4763f9381034efec -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

For chronological validation only

Current affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667725178

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

c6b77b568d772f732dca592a2a8739d880e59a959d8cd182df4c0098addc7b57 -

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/issues/36

 FILE ARCHIVED ON 08:03:02 Nov 06, 2022 AND RETRIEVED FROM THE
 INTERNET ARCHIVE ON 08:59:41 Nov 06, 2022.

fca70c84f5a2e730099dd701366c5e770f9e3e4a98b6a5e2a75e48c74060b7da -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Saturday 05 November 2022 07:22:47 PM IST

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Saturday 05 November 2022 04:21:55 PM IST

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Saturday 05 November 2022 07:22:47 PM IST

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Saturday 05 November 2022 04:21:55 PM IST

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

For chronological validation only

Current affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>

[obonac]

---

Block chain bridge verification

1667725324

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/pull/11

 INTERNET ARCHIVE ON 08:59:40 Nov 06, 2022.
 JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

c6b77b568d772f732dca592a2a8739d880e59a959d8cd182df4c0098addc7b57 -

https://web.archive.org/web/20221106080302/https://github.com/udhc-journals/udhc-journals.github.io/issues/36

 FILE ARCHIVED ON 08:03:02 Nov 06, 2022 AND RETRIEVED FROM THE
 INTERNET ARCHIVE ON 08:59:41 Nov 06, 2022.

fca70c84f5a2e730099dd701366c5e770f9e3e4a98b6a5e2a75e48c74060b7da -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_data

Saturday 05 November 2022 07:22:47 PM IST

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/auth/dummy_auth

Saturday 05 November 2022 04:21:55 PM IST

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_data

Saturday 05 November 2022 07:22:47 PM IST

3772bb7567b1cef2028053ab979258235d11070436d0e717a22f1459d85677df -

https://web.archive.org/web/20221106080302/https://raw.githubusercontent.com/obonac/udhc-journals/master/dataset/dummy_auth

Saturday 05 November 2022 04:21:55 PM IST

46819eb2b5b9a376999ed48b4bdfc28eacd320c2448b801067faa8f5174b746a -

For chronological validation only

Current affairs

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/"

Fri, 14 Oct 2022 13:36:05 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.6 https://www.reutersagency.com/wp-content/uploads/2019/06/fav-150x150.png 32 32 https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-u-s-finds-new-quality-problems-at-lilly-drug-factory/ Tue, 11 Oct 2022 13:34:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=295989 Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co […]

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

The post Reuters reveals U.S. finds new quality problems at Lilly drug factory appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-rotavirus-childhood-vaccine-shortage-hits-four-african-countries/ Tue, 09 Aug 2022 14:56:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293663 Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out […]

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> Reuters exclusively reported that supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, after disruptions at drugmaker GSK. The World Health Organization estimates that up to 200,000 children die each year from the highly contagious infection, which is the leading cause globally of severe, dehydrating gastroenteritis in children under the age of five.

The post Reuters reveals Rotavirus childhood vaccine shortage hits four African countries appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/ Wed, 03 Aug 2022 15:09:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293494 Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit […]

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.

The post Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-indias-pharmeasy-plans-200-million-fundraising-at-lower-valuation/ Sat, 09 Jul 2022 18:58:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=293101 Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise […]

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> Reuters was first to report that Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year’s $5.1 billion. Indian startups have been jolted by uncertain global and domestic stock markets and growing investor skepticism over what they say are sky-high valuations, making it difficult for PharmEasy to raise funds at same or a higher valuation. 

The post Reuters reveals India’s PharmEasy plans $200 million fundraising at lower valuation appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-covid-and-bust-chinas-private-health-system-hurt-by-tough-coronavirus-controls/ Wed, 06 Jul 2022 19:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=292990 Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to […]

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> Reuters offered readers a deep dive into how the diversion of resources into what China calls its ‘zero-COVID’ approach to contain and eliminate the virus forced hospitals to suspend many services it relied upon for revenue, sealing its financial failure. The world’s second-largest economy remains behind several parts of the world by many healthcare measures and is in the middle of a ‘Healthy China’ programme that aims to raise average life expectancy to 79 from 76 by 2030, while increasing survival rates for cancer and other chronic illnesses. Zero-COVID may actually make those goals harder to reach. 

The post Reuters reveals COVID and bust: China’s private health system hurt by tough coronavirus controls appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-chinas-anti-virus-spending-boosts-medical-tech-construction/ Sun, 29 May 2022 15:26:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291742 Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the […]

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> Reuters reported that China’s ‘zero-COVID’ policy of constantly monitoring, testing and isolating its citizens to prevent the spread of the coronavirus has battered much of the country’s economy but has created bubbles of growth in the medical, technology and construction sectors. The Chinese government, alone among major countries in vowing to eradicate the coronavirus within its borders, is on track to spend more than $52 billion this year on testing, new medical facilities, monitoring equipment and other anti-COVID measures, which will benefit as many as 3,000 companies, according to analysts.

The post Reuters reveals China’s anti-virus spending boosts medical, tech, construction appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-telsa-is-idling-shanghai-production-for-two-days-amid-chinas-covid-curbs/ Wed, 16 Mar 2022 19:42:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=291387 Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as […]

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> Reuters was first to report that electric vehicle maker Tesla was suspending production at its Shanghai factory – known as the Gigafactory 3 – for two days this week as China tightens COVID restrictions to attempt to curb an outbreak. The report, based on a notice sent internally and to suppliers, said production was suspended for Wednesday and Thursday at a plant that makes the Model 3 sedan and Model Y crossover for China and export markets. In a separate notice also reviewed by Reuters, Tesla asked suppliers to estimate how many workers would be needed for full production and to provide details of workers affected by COVID restrictions.

The post Reuters reveals Telsa is idling Shanghai production for two days amid China’s COVID curbs appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-encompass-healths-home-health-unit-attracts-acquisition-interest/ Mon, 07 Mar 2022 12:14:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=288628 A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in […]

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> A Reuters exclusive noted that private equity firms including Advent International and companies including Aveanna Healthcare Holdings Inc have expressed interest in acquiring the home health and hospice business of Encompass Health Corp. Encompass, which provides post-acute healthcare services, said in October that it planned to spin off the business, called Enhabit, in the first half of 2022. Last month the Birmingham, Alabama-based company said it was open to the separation happening through a sale or a merger.

The post Reuters Reveals Encompass Health’s home health unit attracts acquisition interest appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-novavax-underdelivers-on-covid-vaccine-promises-market-reacts/ Tue, 08 Feb 2022 20:05:15 +0000 https://www.reutersagency.com/en/?post_type=best&p=287168 Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised […]

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> Reuters revealed that the drugmaker has only delivered a small fraction of the 2 billion COVID-19 vaccines it has promised to governments worldwide and has delayed shipments expected in the first quarter to the European Union, Indonesia and the Philippines. The story, with reporting from the United States, Europe and Asia, also revealed how far behind Novavax is in fulfilling its promises to governments and to COVAX, the global vaccine distribution program that plays a key role in supplying the vaccines to low-income countries. Officials in the Philippines said that they are now seeking to trim their Novavax contract, as a longer-than-expected wait for the company’s vaccine led the country to stockpile supply from other drugmakers. Several industry analysts said they are reviewing their 2022 vaccine sales forecasts of around $5 billion for Novavax in light of the news.

The post Reuters reveals Novavax underdelivers on COVID vaccine promises; market reacts appeared first on Reuters News Agency.

]]> https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-jjs-secret-plan-to-cap-litigation-payouts-to-cancer-victims/ Fri, 04 Feb 2022 14:20:00 +0000 https://www.reutersagency.com/en/?post_type=best&p=287285 On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early […]

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]> On Feb. 4, Reuters revealed in a Special Report that Johnson & Johnson privately took concrete steps starting as early as April 2021 to consider and plan a maneuver, known as a Texas two-step, to shift all its talc liability onto a newly created subsidiary that would immediately file for bankruptcy. The maneuver–J&J’s latest attempt to manage mounting allegations that asbestos lurked in its talc and caused terminal illnesses–halted all litigation against the company and could require plaintiffs to compete in bankruptcy court for compensation from a limited pool of money.

The post Reuters reveals J&J’s secret plan to cap litigation payouts to cancer victims appeared first on Reuters News Agency.

]]>